I V Ozerova Selected Research

I V Ozerova Research Topics

3	Body Weight (Weight, Body) 09/2018 - 01/2013
2	Hyperglycemia 09/2018 - 01/2013
2	Weight Loss (Weight Reduction) 01/2013 - 01/2013
1	Communicable Diseases (Infectious Diseases) 04/2020
1	Extensively Drug-Resistant Tuberculosis 04/2020
1	Pulmonary Tuberculosis 04/2020
1	Tuberculosis (Tuberculoses) 04/2020
1	Polydipsia 09/2018
1	Type 2 Diabetes Mellitus (MODY) 09/2018
1	Hyperphagia (Overeating) 09/2018
1	Thrombosis (Thrombus) 01/2013
1	Pain (Aches) 01/2013

4	Streptozocin (Streptozotocin)FDA Link 09/2018 - 01/2013
2	Hypoglycemic Agents (Hypoglycemics)IBA 09/2018 - 01/2013
1	Isoniazid (Ftivazide)FDA LinkGeneric 04/2020
1	macozinoneIBA 04/2020
1	Rifampin (Rifampicin)FDA LinkGeneric 04/2020
1	2- ((2- morpholino)ethylthio)- 5- ethoxybenzimidazoleIBA 09/2018
1	Metformin (Glucophage)FDA LinkGeneric 09/2018
1	Anti-Anxiety Agents (Anxiolytics)IBA 09/2018
1	Lysine (L-Lysine)FDA Link 01/2013
1	Neuroprotective AgentsIBA 01/2013
1	Nootropic Agents (Nootropics)IBA 01/2013
1	Nerve Growth Factor (NGF)IBA 01/2013
1	DipeptidesIBA 01/2013
1	ethyl phenylacetyl-Pro-GlyIBA 01/2013

1	Therapeutics 04/2020
1	Aftercare (After-Treatment) 09/2018